MCCOLLUM JAMES W
SEC Form 4 insider trading activity
MCCOLLUM JAMES W has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 10, 2025.
On the most recent filing, MCCOLLUM JAMES W is listed as Director at LENZ Therapeutics, Inc. Inside the rolling window, MCCOLLUM JAMES W reported 1 open-market purchase totaling $239K in LENZ and no open-market sales.
Companies traded
Other insiders at LENZ
Insider Buying
$239K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MCCOLLUM JAMES W made?
MCCOLLUM JAMES W has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does MCCOLLUM JAMES W trade?
MCCOLLUM JAMES W has filed SEC Form 4 disclosures for 1 company, including LENZ.
When was MCCOLLUM JAMES W's most recent SEC Form 4 filing?
MCCOLLUM JAMES W's most recent SEC Form 4 filing on Tracefour is dated Nov 10, 2025.
What is MCCOLLUM JAMES W's total buy and sell value in the current window?
Inside the rolling retention window, MCCOLLUM JAMES W bought $239K and sold $0 based on SEC Form 4 filings.
What was MCCOLLUM JAMES W's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,500 LENZ shares on 2025-11-07, worth $239K, per SEC Form 4 filings.